Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Research article

Reduced Dicer expression in the cord blood of infants admitted with severe respiratory syncytial virus disease

Authors: Christopher S Inchley, Tonje Sonerud, Hans O Fjærli, Britt Nakstad

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

Respiratory syncytial virus (RSV) is one of the most important causes of pediatric hospital admissions in the developed world. The ribonuclease Dicer is an important regulator of gene expression and cellular function via RNA interference, and may also have anti-viral functions. A previous microarray analysis of the cord blood of 5 patients with RSV disease suggested downregulation of Dicer. In order to further investigate whether reduced Dicer expression can predispose newborns to RSV disease, we have analyzed the gene expression of Dicer in the cord blood of 37 infants with confirmed RSV disease.

Methods

The cord blood of 2108 newborns was collected. 51 had a positive nasopharyngeal aspirate for RSV <1 year, and were grouped according to disease severity. 37 had sufficient cord blood RNA of good quality. Dicer gene expression was assessed by qPCR analysis of cord blood using a TaqMan low-density array and compared to control infants who did not present with RSV disease using the Mann-Whitney test.

Results

There was significant downregulation of Dicer in the severe disease group: relative quantity 0.69 (95% CI: 0.56 - 0.87), p = 0.002. There was no significant downregulation in the mild disease group.

Conclusions

We demonstrate reduced Dicer expression in the cord blood of infants with severe RSV disease, prior to RSV exposure. We theorize that this may predispose to RSV disease by disruption of leukocyte gene regulation or direct anti-viral RNA interference mechanisms.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kim HW, Arrobio JO, Brandt CD, Jeffries BC, Pyles G, Reid JL, Chanock RM, Parrott RH: Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol. 1973, 98: 216-225.PubMed Kim HW, Arrobio JO, Brandt CD, Jeffries BC, Pyles G, Reid JL, Chanock RM, Parrott RH: Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol. 1973, 98: 216-225.PubMed
2.
go back to reference Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ: Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999, 282: 1440-1446. 10.1001/jama.282.15.1440.CrossRefPubMed Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ: Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999, 282: 1440-1446. 10.1001/jama.282.15.1440.CrossRefPubMed
3.
go back to reference Nokes DJ, Okiro EA, Ngama M, Ochola R, White LJ, Scott PD, English M, Cane PA, Medley GF: Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya. Clin Infect Dis. 2008, 46: 50-57. 10.1086/524019.CrossRefPubMedPubMedCentral Nokes DJ, Okiro EA, Ngama M, Ochola R, White LJ, Scott PD, English M, Cane PA, Medley GF: Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya. Clin Infect Dis. 2008, 46: 50-57. 10.1086/524019.CrossRefPubMedPubMedCentral
4.
go back to reference Mufson MA, Levine HD, Wasil RE, Mocega-Gonzalez HE, Krause HE: Epidemiology of respiratory syncytial virus infection among infants and children in Chicago. Am J Epidemiol. 1973, 98: 88-95.PubMed Mufson MA, Levine HD, Wasil RE, Mocega-Gonzalez HE, Krause HE: Epidemiology of respiratory syncytial virus infection among infants and children in Chicago. Am J Epidemiol. 1973, 98: 88-95.PubMed
5.
go back to reference Karron RA, Singleton RJ, Bulkow L, Parkinson A, Kruse D, DeSmet I, Indorf C, Petersen KM, Leombruno D, Hurlburt D, et al: Severe respiratory syncytial virus disease in Alaska native children. RSV Alaska Study Group. J Infect Dis. 1999, 180: 41-49. 10.1086/314841.CrossRefPubMed Karron RA, Singleton RJ, Bulkow L, Parkinson A, Kruse D, DeSmet I, Indorf C, Petersen KM, Leombruno D, Hurlburt D, et al: Severe respiratory syncytial virus disease in Alaska native children. RSV Alaska Study Group. J Infect Dis. 1999, 180: 41-49. 10.1086/314841.CrossRefPubMed
6.
go back to reference Glezen WP, Taber LH, Frank AL, Kasel JA: Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986, 140: 543-546.PubMed Glezen WP, Taber LH, Frank AL, Kasel JA: Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986, 140: 543-546.PubMed
7.
go back to reference Brandt CD, Kim HW, Arrobio JO, Jeffries BC, Wood SC, Chanock RM, Parrott RH: Epidemiology of respiratory syncytial virus infection in Washington, D.C. 3. Composite analysis of eleven consecutive yearly epidemics. Am J Epidemiol. 1973, 98: 355-364.PubMed Brandt CD, Kim HW, Arrobio JO, Jeffries BC, Wood SC, Chanock RM, Parrott RH: Epidemiology of respiratory syncytial virus infection in Washington, D.C. 3. Composite analysis of eleven consecutive yearly epidemics. Am J Epidemiol. 1973, 98: 355-364.PubMed
8.
go back to reference Fjaerli HO, Farstad T, Rod G, Ufert GK, Gulbrandsen P, Nakstad B: Acute bronchiolitis in infancy as risk factor for wheezing and reduced pulmonary function by seven years in Akershus County, Norway. BMC Pediatr. 2005, 5: 31-10.1186/1471-2431-5-31.CrossRefPubMedPubMedCentral Fjaerli HO, Farstad T, Rod G, Ufert GK, Gulbrandsen P, Nakstad B: Acute bronchiolitis in infancy as risk factor for wheezing and reduced pulmonary function by seven years in Akershus County, Norway. BMC Pediatr. 2005, 5: 31-10.1186/1471-2431-5-31.CrossRefPubMedPubMedCentral
9.
go back to reference Fjaerli HO, Farstad T, Bratlid D: Hospitalisations for respiratory syncytial virus bronchiolitis in Akershus, Norway, 1993-2000: a population-based retrospective study. BMC Pediatr. 2004, 4: 25-10.1186/1471-2431-4-25.CrossRefPubMedPubMedCentral Fjaerli HO, Farstad T, Bratlid D: Hospitalisations for respiratory syncytial virus bronchiolitis in Akershus, Norway, 1993-2000: a population-based retrospective study. BMC Pediatr. 2004, 4: 25-10.1186/1471-2431-4-25.CrossRefPubMedPubMedCentral
10.
go back to reference Leader S, Kohlhase K: Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999. Pediatr Infect Dis J. 2002, 21: 629-632. 10.1097/00006454-200207000-00005.CrossRefPubMed Leader S, Kohlhase K: Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999. Pediatr Infect Dis J. 2002, 21: 629-632. 10.1097/00006454-200207000-00005.CrossRefPubMed
11.
go back to reference Amanatidou V, Apostolakis S, Spandidos DA: Genetic diversity of the host and severe respiratory syncytial virus-induced lower respiratory tract infection. Pediatr Infect Dis J. 2009, 28: 135-140. 10.1097/INF.0b013e31818c8d17.CrossRefPubMed Amanatidou V, Apostolakis S, Spandidos DA: Genetic diversity of the host and severe respiratory syncytial virus-induced lower respiratory tract infection. Pediatr Infect Dis J. 2009, 28: 135-140. 10.1097/INF.0b013e31818c8d17.CrossRefPubMed
12.
go back to reference Collins PL, Graham BS: Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol. 2008, 82: 2040-2055. 10.1128/JVI.01625-07.CrossRefPubMed Collins PL, Graham BS: Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol. 2008, 82: 2040-2055. 10.1128/JVI.01625-07.CrossRefPubMed
13.
go back to reference Forton JT, Rowlands K, Rockett K, Hanchard N, Herbert M, Kwiatkowski DP, Hull J: Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster. Thorax. 2009, 64: 345-352. 10.1136/thx.2008.102111.CrossRefPubMedPubMedCentral Forton JT, Rowlands K, Rockett K, Hanchard N, Herbert M, Kwiatkowski DP, Hull J: Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster. Thorax. 2009, 64: 345-352. 10.1136/thx.2008.102111.CrossRefPubMedPubMedCentral
14.
go back to reference Janssen R, Bont L, Siezen CL, Hodemaekers HM, Ermers MJ, Doornbos G, van't Slot R, Wijmenga C, Goeman JJ, Kimpen JL, et al: Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J Infect Dis. 2007, 196: 826-834. 10.1086/520886.CrossRefPubMed Janssen R, Bont L, Siezen CL, Hodemaekers HM, Ermers MJ, Doornbos G, van't Slot R, Wijmenga C, Goeman JJ, Kimpen JL, et al: Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J Infect Dis. 2007, 196: 826-834. 10.1086/520886.CrossRefPubMed
15.
go back to reference Siezen CL, Bont L, Hodemaekers HM, Ermers MJ, Doornbos G, Van't Slot R, Wijmenga C, Houwelingen HC, Kimpen JL, Kimman TG, et al: Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes. Pediatr Infect Dis J. 2009, 28: 333-335. 10.1097/INF.0b013e31818e2aa9.CrossRefPubMed Siezen CL, Bont L, Hodemaekers HM, Ermers MJ, Doornbos G, Van't Slot R, Wijmenga C, Houwelingen HC, Kimpen JL, Kimman TG, et al: Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes. Pediatr Infect Dis J. 2009, 28: 333-335. 10.1097/INF.0b013e31818e2aa9.CrossRefPubMed
16.
go back to reference Power UF: Respiratory syncytial virus (RSV) vaccines--Two steps back for one leap forward. Journal of Clinical Virology. 2008, 41: 38-44. 10.1016/j.jcv.2007.10.024.CrossRefPubMed Power UF: Respiratory syncytial virus (RSV) vaccines--Two steps back for one leap forward. Journal of Clinical Virology. 2008, 41: 38-44. 10.1016/j.jcv.2007.10.024.CrossRefPubMed
17.
go back to reference Oshansky CM, Zhang W, Moore E, Tripp RA: The host response and molecular pathogenesis associated with respiratory syncytial virus infection. Future Microbiology. 2009, 4: 279-297. 10.2217/fmb.09.1.CrossRefPubMedPubMedCentral Oshansky CM, Zhang W, Moore E, Tripp RA: The host response and molecular pathogenesis associated with respiratory syncytial virus infection. Future Microbiology. 2009, 4: 279-297. 10.2217/fmb.09.1.CrossRefPubMedPubMedCentral
18.
go back to reference Krol J, Loedige I, Filipowicz W: The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010, 11: 597-610.PubMed Krol J, Loedige I, Filipowicz W: The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010, 11: 597-610.PubMed
19.
go back to reference de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J: Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov. 2007, 6: 443-453. 10.1038/nrd2310.CrossRefPubMed de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J: Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov. 2007, 6: 443-453. 10.1038/nrd2310.CrossRefPubMed
20.
go back to reference Muller S, Imler JL: Dicing with viruses: microRNAs as antiviral factors. Immunity. 2007, 27: 1-3. 10.1016/j.immuni.2007.07.003.CrossRefPubMed Muller S, Imler JL: Dicing with viruses: microRNAs as antiviral factors. Immunity. 2007, 27: 1-3. 10.1016/j.immuni.2007.07.003.CrossRefPubMed
21.
go back to reference Matskevich AA, Moelling K: Dicer is involved in protection against influenza A virus infection. J Gen Virol. 2007, 88: 2627-2635. 10.1099/vir.0.83103-0.CrossRefPubMed Matskevich AA, Moelling K: Dicer is involved in protection against influenza A virus infection. J Gen Virol. 2007, 88: 2627-2635. 10.1099/vir.0.83103-0.CrossRefPubMed
22.
go back to reference Aliyari R, Ding SW: RNA-based viral immunity initiated by the Dicer family of host immune receptors. Immunol Rev. 2009, 227: 176-188. 10.1111/j.1600-065X.2008.00722.x.CrossRefPubMedPubMedCentral Aliyari R, Ding SW: RNA-based viral immunity initiated by the Dicer family of host immune receptors. Immunol Rev. 2009, 227: 176-188. 10.1111/j.1600-065X.2008.00722.x.CrossRefPubMedPubMedCentral
23.
go back to reference DeVincenzo J, Lambkin-Williams R, Wilkinson T, Cehelsky J, Nochur S, Walsh E, Meyers R, Gollob J, Vaishnaw A: A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc Natl Acad Sci USA. 2010, 107: 8800-8805. 10.1073/pnas.0912186107.CrossRefPubMedPubMedCentral DeVincenzo J, Lambkin-Williams R, Wilkinson T, Cehelsky J, Nochur S, Walsh E, Meyers R, Gollob J, Vaishnaw A: A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc Natl Acad Sci USA. 2010, 107: 8800-8805. 10.1073/pnas.0912186107.CrossRefPubMedPubMedCentral
24.
go back to reference Alvarez R, Elbashir S, Borland T, Toudjarska I, Hadwiger P, John M, Roehl I, Morskaya SS, Martinello R, Kahn J, et al: RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy. Antimicrob Agents Chemother. 2009, 53: 3952-3962. 10.1128/AAC.00014-09.CrossRefPubMedPubMedCentral Alvarez R, Elbashir S, Borland T, Toudjarska I, Hadwiger P, John M, Roehl I, Morskaya SS, Martinello R, Kahn J, et al: RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy. Antimicrob Agents Chemother. 2009, 53: 3952-3962. 10.1128/AAC.00014-09.CrossRefPubMedPubMedCentral
25.
go back to reference Fjaerli HO, Bukholm G, Skjaeret C, Holden M, Nakstad B: Cord blood gene expression in infants hospitalized with respiratory syncytial virus bronchiolitis. J Infect Dis. 2007, 196: 394-404. 10.1086/519168.CrossRefPubMed Fjaerli HO, Bukholm G, Skjaeret C, Holden M, Nakstad B: Cord blood gene expression in infants hospitalized with respiratory syncytial virus bronchiolitis. J Infect Dis. 2007, 196: 394-404. 10.1086/519168.CrossRefPubMed
26.
go back to reference Olsen MA, Shuck KM, Sambol AR: Evaluation of Abbott TestPack RSV for the diagnosis of respiratory syncytial virus infections. Diagn Microbiol Infect Dis. 1993, 16: 105-109. 10.1016/0732-8893(93)90003-P.CrossRefPubMed Olsen MA, Shuck KM, Sambol AR: Evaluation of Abbott TestPack RSV for the diagnosis of respiratory syncytial virus infections. Diagn Microbiol Infect Dis. 1993, 16: 105-109. 10.1016/0732-8893(93)90003-P.CrossRefPubMed
27.
go back to reference Kehl SC, Henrickson KJ, Hua W, Fan J: Evaluation of the Hexaplex assay for detection of respiratory viruses in children. J Clin Microbiol. 2001, 39: 1696-1701. 10.1128/JCM.39.5.1696-1701.2001.CrossRefPubMedPubMedCentral Kehl SC, Henrickson KJ, Hua W, Fan J: Evaluation of the Hexaplex assay for detection of respiratory viruses in children. J Clin Microbiol. 2001, 39: 1696-1701. 10.1128/JCM.39.5.1696-1701.2001.CrossRefPubMedPubMedCentral
28.
go back to reference Stevens TP, Sinkin RA, Hall CB, Maniscalco WM, McConnochie KM: Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis. Arch Pediatr Adolesc Med. 2000, 154: 55-61.PubMed Stevens TP, Sinkin RA, Hall CB, Maniscalco WM, McConnochie KM: Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis. Arch Pediatr Adolesc Med. 2000, 154: 55-61.PubMed
29.
go back to reference Fixler DE: Respiratory syncytial virus infection in children with congenital heart disease: a review. Pediatr Cardiol. 1996, 17: 163-168. 10.1007/BF02505206.CrossRefPubMed Fixler DE: Respiratory syncytial virus infection in children with congenital heart disease: a review. Pediatr Cardiol. 1996, 17: 163-168. 10.1007/BF02505206.CrossRefPubMed
30.
go back to reference Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.CrossRefPubMed Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.CrossRefPubMed
31.
go back to reference Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, et al: The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments. Clinical Chemistry. 2009, 55: 611-622. 10.1373/clinchem.2008.112797.CrossRefPubMed Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, et al: The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments. Clinical Chemistry. 2009, 55: 611-622. 10.1373/clinchem.2008.112797.CrossRefPubMed
33.
go back to reference O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D: Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 2010, 10: 111-122.CrossRefPubMed O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D: Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 2010, 10: 111-122.CrossRefPubMed
34.
go back to reference Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick AM, et al: Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med. 2008, 359: 2641-2650. 10.1056/NEJMoa0803785.CrossRefPubMedPubMedCentral Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick AM, et al: Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med. 2008, 359: 2641-2650. 10.1056/NEJMoa0803785.CrossRefPubMedPubMedCentral
35.
go back to reference Wu JF, Shen W, Liu NZ, Zeng GL, Yang M, Zuo GQ, Gan XN, Ren H, Tang KF: Down-regulation of Dicer in hepatocellular carcinoma. Med Oncol. 2010 Wu JF, Shen W, Liu NZ, Zeng GL, Yang M, Zuo GQ, Gan XN, Ren H, Tang KF: Down-regulation of Dicer in hepatocellular carcinoma. Med Oncol. 2010
36.
go back to reference Grelier G, Voirin N, Ay AS, Cox DG, Chabaud S, Treilleux I, Leon-Goddard S, Rimokh R, Mikaelian I, Venoux C, et al: Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. Br J Cancer. 2009, 101: 673-683. 10.1038/sj.bjc.6605193.CrossRefPubMedPubMedCentral Grelier G, Voirin N, Ay AS, Cox DG, Chabaud S, Treilleux I, Leon-Goddard S, Rimokh R, Mikaelian I, Venoux C, et al: Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. Br J Cancer. 2009, 101: 673-683. 10.1038/sj.bjc.6605193.CrossRefPubMedPubMedCentral
37.
go back to reference Muljo SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao A, Rajewsky K: Aberrant T cell differentiation in the absence of Dicer. J Exp Med. 2005, 202: 261-269. 10.1084/jem.20050678.CrossRefPubMedPubMedCentral Muljo SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao A, Rajewsky K: Aberrant T cell differentiation in the absence of Dicer. J Exp Med. 2005, 202: 261-269. 10.1084/jem.20050678.CrossRefPubMedPubMedCentral
38.
go back to reference Cobb BS, Hertweck A, Smith J, O'Connor E, Graf D, Cook T, Smale ST, Sakaguchi S, Livesey FJ, Fisher AG, Merkenschlager M: A role for Dicer in immune regulation. J Exp Med. 2006, 203: 2519-2527. 10.1084/jem.20061692.CrossRefPubMedPubMedCentral Cobb BS, Hertweck A, Smith J, O'Connor E, Graf D, Cook T, Smale ST, Sakaguchi S, Livesey FJ, Fisher AG, Merkenschlager M: A role for Dicer in immune regulation. J Exp Med. 2006, 203: 2519-2527. 10.1084/jem.20061692.CrossRefPubMedPubMedCentral
39.
go back to reference Fedeli M, Napolitano A, Wong MP, Marcais A, de Lalla C, Colucci F, Merkenschlager M, Dellabona P, Casorati G: Dicer-dependent microRNA pathway controls invariant NKT cell development. J Immunol. 2009, 183: 2506-2512. 10.4049/jimmunol.0901361.CrossRefPubMed Fedeli M, Napolitano A, Wong MP, Marcais A, de Lalla C, Colucci F, Merkenschlager M, Dellabona P, Casorati G: Dicer-dependent microRNA pathway controls invariant NKT cell development. J Immunol. 2009, 183: 2506-2512. 10.4049/jimmunol.0901361.CrossRefPubMed
40.
go back to reference Kuipers H, Schnorfeil FM, Fehling HJ, Bartels H, Brocker T: Dicer-dependent microRNAs control maturation, function, and maintenance of Langerhans cells in vivo. J Immunol. 2010, 185: 400-409. 10.4049/jimmunol.0903912.CrossRefPubMed Kuipers H, Schnorfeil FM, Fehling HJ, Bartels H, Brocker T: Dicer-dependent microRNAs control maturation, function, and maintenance of Langerhans cells in vivo. J Immunol. 2010, 185: 400-409. 10.4049/jimmunol.0903912.CrossRefPubMed
41.
go back to reference Krishnan S, Halonen M, Welliver RC: Innate immune responses in respiratory syncytial virus infections. Viral Immunol. 2004, 17: 220-233. 10.1089/0882824041310612.CrossRefPubMed Krishnan S, Halonen M, Welliver RC: Innate immune responses in respiratory syncytial virus infections. Viral Immunol. 2004, 17: 220-233. 10.1089/0882824041310612.CrossRefPubMed
42.
go back to reference Webb TJ, Sumpter TL, Thiele AT, Swanson KA, Wilkes DS: The phenotype and function of lung dendritic cells. Crit Rev Immunol. 2005, 25: 465-491.CrossRefPubMed Webb TJ, Sumpter TL, Thiele AT, Swanson KA, Wilkes DS: The phenotype and function of lung dendritic cells. Crit Rev Immunol. 2005, 25: 465-491.CrossRefPubMed
43.
go back to reference Whitehead KA, Langer R, Anderson DG: Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov. 2009, 8: 129-138. 10.1038/nrd2742.CrossRefPubMed Whitehead KA, Langer R, Anderson DG: Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov. 2009, 8: 129-138. 10.1038/nrd2742.CrossRefPubMed
44.
go back to reference Huang DD: The potential of RNA interference-based therapies for viral infections. Curr HIV/AIDS Rep. 2008, 5: 33-39. 10.1007/s11904-008-0006-4.CrossRefPubMed Huang DD: The potential of RNA interference-based therapies for viral infections. Curr HIV/AIDS Rep. 2008, 5: 33-39. 10.1007/s11904-008-0006-4.CrossRefPubMed
45.
go back to reference Deffrasnes C, Cavanagh MH, Goyette N, Cui K, Ge Q, Seth S, Templin MV, Quay SC, Johnson PH, Boivin G: Inhibition of human metapneumovirus replication by small interfering RNA. Antivir Ther. 2008, 13: 821-832.PubMed Deffrasnes C, Cavanagh MH, Goyette N, Cui K, Ge Q, Seth S, Templin MV, Quay SC, Johnson PH, Boivin G: Inhibition of human metapneumovirus replication by small interfering RNA. Antivir Ther. 2008, 13: 821-832.PubMed
46.
go back to reference Zamora MR, Budev M, Rolfe M, Gottlieb J, Humar A, Devincenzo J, Vaishnaw A, Cehelsky J, Albert G, Nochur S, et al: RNA interference therapy in lung transplant patients infected with respiratory syncytial virus. Am J Respir Crit Care Med. 2010, 183: 531-538. 10.1164/rccm.201003-0422OC.CrossRefPubMed Zamora MR, Budev M, Rolfe M, Gottlieb J, Humar A, Devincenzo J, Vaishnaw A, Cehelsky J, Albert G, Nochur S, et al: RNA interference therapy in lung transplant patients infected with respiratory syncytial virus. Am J Respir Crit Care Med. 2010, 183: 531-538. 10.1164/rccm.201003-0422OC.CrossRefPubMed
47.
go back to reference Wiesen JL, Tomasi TB: Dicer is regulated by cellular stresses and interferons. Mol Immunol. 2009, 46: 1222-1228. 10.1016/j.molimm.2008.11.012.CrossRefPubMed Wiesen JL, Tomasi TB: Dicer is regulated by cellular stresses and interferons. Mol Immunol. 2009, 46: 1222-1228. 10.1016/j.molimm.2008.11.012.CrossRefPubMed
Metadata
Title
Reduced Dicer expression in the cord blood of infants admitted with severe respiratory syncytial virus disease
Authors
Christopher S Inchley
Tonje Sonerud
Hans O Fjærli
Britt Nakstad
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-59

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.